NCT06093932View on ClinicalTrials.gov

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 7, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Hypertension,Essential
Interventions
DRUG

Songling Xuemaikang Capsules

3 capsules at a time, three times a day, duration: 12 weeks

BEHAVIORAL

Lifestyle intervention

everyday, duration: 12 weeks

DRUG

Placebo

3 capsules at a time, three times a day, duration: 12 weeks

Trial Locations (5)

100091

RECRUITING

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing

215002

NOT_YET_RECRUITING

Suzhou Hosptial of Traditional Chinese Medicine, Suzhou

250013

NOT_YET_RECRUITING

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan

272000

NOT_YET_RECRUITING

China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital, Jining

030024

NOT_YET_RECRUITING

China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital, Taiyuan

All Listed Sponsors
collaborator

China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital

UNKNOWN

collaborator

Suzhou Hosptial of Traditional Chinese Medicine

UNKNOWN

collaborator

China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital

UNKNOWN

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

lead

Xiyuan Hospital of China Academy of Chinese Medical Sciences

OTHER